S. Schön

发表

Cloning and Recombinant Expression of Active Full-length Xylosyltransferase I (XT-I) and Characterization of Subcellular Localization of XT-I and XT-II*

K. Kleesiek, C. Prante, J. Kuhn, 2006, Journal of Biological Chemistry.

Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome.

H. Müller-Hermelink, H. Caffier, S. Schön, 1998, Journal of clinical pathology.

Complement 5a receptor inhibition improves renal allograft survival.

K. Schnatbaum, T. Greten, S. Rong, 2008, Journal of the American Society of Nephrology : JASN.

Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24).

M. Schnölzer, K. Kleesiek, C. Prante, 2005, Biochemical and biophysical research communications.

Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course

K. Kleesiek, C. Prante, J. Kuhn, 2006, Journal of Medical Genetics.

Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis

K. Kleesiek, J. Kuhn, D. Hendig, 2005, Journal of Molecular Medicine.

Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry.

K. Kleesiek, C. Prante, J. Kuhn, 2006, Clinical chemistry.

Transforming Growth Factor β1-regulated Xylosyltransferase I Activity in Human Cardiac Fibroblasts and Its Impact for Myocardial Remodeling*

R. Körfer, H. Milting, K. Kleesiek, 2007, Journal of Biological Chemistry.

Complement 5a receptor inhibition improves renal allograft survival.

K. Schnatbaum, T. Greten, S. Rong, 2008, Journal of the American Society of Nephrology : JASN.

Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme.

Joachim Kuhn, Thomas Brinkmann, K. Kleesiek, 2006, The Biochemical journal.

Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiency.

K. Kleesiek, C. Prante, J. Kuhn, 2005, Clinical biochemistry.

Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.

K. Kleesiek, C. Prante, J. Kuhn, 2005, The Biochemical journal.

Analysis of the DXD Motifs in Human Xylosyltransferase I Required for Enzyme Activity*

K. Kleesiek, C. Prante, J. Kuhn, 2004, Journal of Biological Chemistry.

High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form.

M. Schnölzer, K. Kleesiek, T. Kempf, 2003, Biochemical and biophysical research communications.

Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy.

L. Tarnow, K. Kleesiek, C. Prante, 2005, Kidney international.